Featured Video  

New Release! Free On-Demand CE Pharmacy Technician Credit Offered & Qualifies for Compounding CE The United States Pharmacopeia General Chapter 797 (USP <797>) defines the minimum standards for sterile compounding that are critical for patient safety. This educational activity will focus on the practical application of these standards when assigning beyond-use dates (BUDs) for compounded sterile preparations (CSPs). Pharmacists, pharmacy technicians, and medication safety officers frequently encounter challenges when determining appropriate BUDs due to variations in compounding environments, facility compliance levels, and operational workflows. Participants will explore how BUD determinations may differ across practice settings such as fully compliant cleanroom suites and segregated compounding areas. In this interactive web-based activity, learners will apply these concepts to real-world situations, reinforcing how facility-specific conditions can impact appropriate BUD selection for CSPs.  We invite you to share this free educational activity with your colleagues. MPA, BCSCP, FASHP
Activity Chair    Director, Accreditation and Medication Safety
Cardinal Health
Wilkes-Barre, Pennsylvania PharmD, BCPS, BCSCP     System Sterile Compounding Services Specialist
Prisma Health Department of Pharmacy
Columbia, South Carolina  This activity was planned to meet the educational needs of pharmacists, pharmacy technicians, and medication safety officers practicing in hospitals and health systems, including all settings responsible for preparing, labeling, packaging, storing, and distributing compounded sterile preparations. ACPE #: 0204-0000-26-403-H07-P, 0204-0000-26-403-H07-T CE Credit: 0.75 contact hours (0.075 CEUs) Activity Type: Application-based Activity Fee: No charge  Available: June 15, 2026 - June 15, 2027
To receive CE credit, complete the steps below within 60 days of completing the activity. After the 60-day deadline, ASHP will no longer be able to report credit(s).   View all of the other ASHP Advantage activities offered online. We invite you to share these free educational activities with your colleagues. Provided by ASHP.
Supported by an educational grant from Pfizer Inc. For questions and assistance to participate, contact us.

Free On-Demand CE!
Learn More About Ready to Administer Products Offers CPEL Recertification Credit This educational activity will review the evidence for the safety and cost-effectiveness of ready-to-administer (RTA) prefilled syringes compared to the traditional vial-and-syringe method, present the latest study on pharmacy-related costs associated with IV push products, and discuss real-world aspects of transitioning from traditional to RTA products. Faculty will discuss barriers, challenges, and the data and information needed to build an institution-specific value proposition to persuade decision makers to adopt or expand use of RTA prefilled syringes. Participants will be guided by faculty to begin to develop their own specific plans for adoption or expanded use of RTA prefilled syringes at their practice sites.   We invite you to share this free educational activity with your colleagues.    PharmD, MS, CPPS, FASHP, FFIP Activity Chair   Founder Hertig Healthcare Advising, LLC Adjunct Assistant Professor Purdue University
Indianapolis, Indiana PharmD, MS, MBA, CPEL  
Vice President of Ambulatory Pharmacy Emory Healthcare Winship Cancer Institute Atlanta, Georgia   This activity was planned to meet the educational needs of pharmacists in leadership positions including pharmacy executives, managers and supervisors, front-line clinical pharmacists and those in product procurement roles who can identify specific opportunities for realizing benefit from the use of ready-to-administer (RTA) prefilled syringes.  Welcome and Introductions
John Hertig
  Review of the Evidence: Safety and Cost-Effectiveness of RTA Prefilled Syringes  John Hertig
  Pharmacy Costs Associated with IV Push Products All Faculty
  RTA: Real-World Barriers, Challenges and Success Stories Ryan Haumschild
  Hot Topic Discussion All Faculty   Faculty Discussion, Questions and Answers All Faculty ACPE #: 0204-0000-25-412-H04-P CE Credit: 1.5 contact hours (0.15 CEUs) Activity Type: Application-based Activity Fee: No charge  Available: February 26, 2026 - February 26, 2027   To receive CE credit, complete the steps below within 60 days of completing the activity. After the 60-day deadline, ASHP will no longer be able to report credit(s).    View all of the ASHP Advantage activities offered online. We invite you to share these free educational activities with your colleagues.    

  Featured Video

臺灣血液腫瘤藥學會對衛福部提出癌症病人居家接受化學治療之回應：可行性、潛在衝擊、配套及城鄉差距
提出日期：2026/6/11 (臺灣血液腫瘤藥學會理監事臨時會議)
 
背景
2026年6月10日衛福部長在立法院衛環委員會中表示，參考法國居家醫療制度，為了空出住院床位，讓醫療護理人力更有效地運用，推動癌症病人第二次化學治療注射劑可以在家接受給藥。臺灣血液腫瘤藥學會以對於抗癌藥品注射劑的危害性與無菌性的考量，針對醫療人員的安全防護、家屬的暴露、環境的保護，以及最重要的病人安全，提出各項應考慮的配套措施。
 
分析與討論
一、 核心議題釐清：何謂「居家化療」？
衛福部必須先釐清所謂「居家化療」的具體定義與實行模式，其可行性有極大差異，本會專家們有兩種模式的了解： 二、 推動模式二之主要臨床與實務挑戰 注射型抗癌藥品是必須考量無菌性與危害性的藥品： 我們的建議    
 

From Conference to Practice: Top 5 Takeaways From EHA 2026

Read More   FDA Approves Gadoquatrane to Detect CNS and Non-CNS Body Region Lesions

Read More Videos

Watch Now

Watch Now Trending

Read More

Read More